-
公开(公告)号:US20230386640A1
公开(公告)日:2023-11-30
申请号:US18449332
申请日:2023-08-14
Applicant: POPS! Diabetes Care, Inc.
Inventor: Curtis Christensen , Daniel Davis , Erik Davis , Chandler Stormo , Lonny Stormo
IPC: G16H20/30 , A61B5/00 , A61B5/145 , A61B5/151 , A61B5/157 , A61B5/11 , A61B5/1171 , G16H40/63 , G16H10/20 , G16H40/60 , G16H10/60 , G06Q30/0251 , G06Q30/0241 , G09B5/12 , G09B19/00 , H04L9/40
CPC classification number: G16H20/30 , A61B5/486 , A61B5/6898 , A61B5/14532 , A61B5/151 , A61B5/157 , A61B5/1118 , A61B5/1176 , A61B5/7275 , A61B5/0022 , A61B5/742 , A61B5/7475 , G16H40/63 , G16H10/20 , G16H40/60 , G16H10/60 , A61B5/7282 , A61B5/746 , G06Q30/0269 , G06Q30/0277 , G09B5/125 , G09B19/0092 , H04L63/10 , A61B2562/0295
Abstract: Methods and systems are disclosed for prompting a patient to take a blood glucose management action. A diabetes management application on a mobile device can receive diabetes-related information from the mobile device. The diabetes management application can identify a blood glucose management action prompt based on a comparison of the received diabetes-related information to one or more predetermined prompt criteria. The diabetes management application can generate a blood glucose management action prompt based on the blood glucose management action prompt condition. The diabetes management application can present the blood glucose management action prompt to the patient on a user interface of the mobile device.
-
公开(公告)号:US20160324464A1
公开(公告)日:2016-11-10
申请号:US15149119
申请日:2016-05-07
Applicant: POPS! Diabetes Care, Inc.
Inventor: Curtis Christensen , Daniel Davis , Erik Davis , Chandler Stormo , Lonny Stormo
CPC classification number: A61B5/7275 , A61B5/0022 , A61B5/1118 , A61B5/1176 , A61B5/14532 , A61B5/151 , A61B5/157 , A61B5/486 , A61B5/6898 , A61B5/7282 , A61B5/742 , A61B5/746 , A61B5/7475 , A61B2562/0295 , G06F19/321 , G06F19/3475 , G06F19/3481 , G06Q30/0269 , G06Q30/0277 , G09B5/125 , G09B19/0092 , G16H10/20 , G16H40/63 , H04L63/10
Abstract: Methods and systems are disclosed for prompting a patient to take a blood glucose management action. A diabetes management application on a mobile device can receive diabetes-related information from the mobile device. The diabetes management application can identify a blood glucose management action prompt based on a comparison of the received diabetes-related information to one or more predetermined prompt criteria. The diabetes management application can generate a blood glucose management action prompt based on the blood glucose management action prompt condition. The diabetes management application can present the blood glucose management action prompt to the patient on a user interface of the mobile device.
-
公开(公告)号:US20240000353A1
公开(公告)日:2024-01-04
申请号:US18470167
申请日:2023-09-19
Applicant: POPS! Diabetes Care, Inc.
Inventor: Curtis Christensen , Daniel W. Davis , Erik D. Davis
CPC classification number: A61B5/150572 , A61B5/15101 , A61B5/150267 , A61B5/150862 , A61B5/15087 , A61B5/15151 , A61B5/15163 , A61B5/150022 , A61B5/150412 , A61B5/150969 , A61B5/15105 , A61B5/15142 , A61B5/150358 , A61B5/157 , A61B5/150893 , A61B5/1411 , A61B5/14532 , A61B5/7405 , A61B5/742 , A61B5/7455 , A61B5/15019 , A61B5/150213 , A61B5/150503 , A61B5/150633 , A61B5/150664 , A61B5/15144 , A61B2560/0443 , A61B5/7445 , A61B2562/0295
Abstract: This disclosure provides equipment and processes for blood glucose management. Embodiments may comprise a lancet device that includes a base that supports a lancet and a cover. The cover can move controllably from an un-depressed position to a depressed position when a predetermined force is applied. The cover can provide access to the lancet in the depressed position. In another aspect, a biological test kit may include a reusable module and a disposable module. The disposable module may include one or more lancet devices such as that described above to collect a biological sample, one or more strip stations supporting biological strips and a disposable module connector. The reusable module may support measuring equipment to measure a property of the biological sample and a reusable module connector that engages removably with the disposable module connector.
-
公开(公告)号:US20160120452A1
公开(公告)日:2016-05-05
申请号:US14995652
申请日:2016-01-14
Applicant: POPS! Diabetes Care, Inc.
Inventor: Curtis Christensen , Daniel Davis , Erik Davis
CPC classification number: A61B5/150572 , A61B5/1411 , A61B5/14532 , A61B5/150022 , A61B5/15019 , A61B5/150213 , A61B5/150267 , A61B5/150358 , A61B5/150412 , A61B5/150503 , A61B5/150633 , A61B5/150664 , A61B5/150862 , A61B5/15087 , A61B5/150893 , A61B5/150969 , A61B5/15101 , A61B5/15105 , A61B5/15142 , A61B5/15144 , A61B5/15151 , A61B5/15163 , A61B5/157 , A61B5/7405 , A61B5/742 , A61B5/7445 , A61B5/7455 , A61B2560/0443 , A61B2562/0295
Abstract: This disclosure provides equipment and processes for blood glucose management. Embodiments may comprise a lancet device that includes a base that supports a lancet and a cover. The cover can move controllably from an un-depressed position to a depressed position when a predetermined force is applied. The cover can provide access to the lancet in the depressed position. In another aspect, a biological test kit may include a reusable module and a disposable module. The disposable module may include one or more lancet devices such as that described above to collect a biological sample, one or more strip stations supporting biological strips and a disposable module connector. The reusable module may support measuring equipment to measure a property of the biological sample and a reusable module connector that engages removably with the disposable module connector.
Abstract translation: 本公开提供了血糖管理的设备和方法。 实施例可以包括刺血针装置,其包括支撑柳叶刀和盖的基部。 当施加预定的力时,盖可以从未按压位置可控地移动到压下位置。 盖可以提供在踩下位置的柳叶刀的通路。 在另一方面,生物测试试剂盒可以包括可重复使用的模块和一次性模块。 一次性模块可以包括一个或多个刺血针装置,例如上述用于收集生物样品的一个或多个刺血针装置,支撑生物条的一个或多个条状台和一次性模块连接器。 可重复使用的模块可以支持测量设备来测量生物样品的性质,以及可重复使用的模块连接器,其可拆卸地与一次性模块连接器接合。
-
公开(公告)号:US20200375517A1
公开(公告)日:2020-12-03
申请号:US16998157
申请日:2020-08-20
Applicant: POPS! Diabetes Care, Inc.
Inventor: Curtis Christensen , Daniel Davis , Erik Davis
Abstract: This disclosure provides equipment and processes for blood glucose management. Embodiments may comprise a lancet device that includes a base that supports a lancet and a cover. The cover can move controllably from an un-depressed position to a depressed position when a predetermined force is applied. The cover can provide access to the lancet in the depressed position. In another aspect, a biological test kit may include a reusable module and a disposable module. The disposable module may include one or more lancet devices such as that described above to collect a biological sample, one or more strip stations supporting biological strips and a disposable module connector. The reusable module may support measuring equipment to measure a property of the biological sample and a reusable module connector that engages removably with the disposable module connector.
-
公开(公告)号:US20160328527A1
公开(公告)日:2016-11-10
申请号:US15149120
申请日:2016-05-07
Applicant: POPS! Diabetes Care, Inc.
Inventor: Curtis Christensen , Daniel Davis , Erik Davis , Chandler Stormo , Lonny Stomo
CPC classification number: A61B5/7275 , A61B5/0022 , A61B5/1118 , A61B5/1176 , A61B5/14532 , A61B5/151 , A61B5/157 , A61B5/486 , A61B5/6898 , A61B5/7282 , A61B5/742 , A61B5/746 , A61B5/7475 , A61B2562/0295 , G06F19/321 , G06F19/3475 , G06F19/3481 , G06Q30/0269 , G06Q30/0277 , G09B5/125 , G09B19/0092 , G16H10/20 , G16H40/63 , H04L63/10
Abstract: Methods and systems are disclosed for prompting a patient to take a blood glucose management action. A diabetes management application on a mobile device can receive diabetes-related information from the mobile device. The diabetes management application can identify a blood glucose management action prompt based on a comparison of the received diabetes-related information to one or more predetermined prompt criteria. The diabetes management application can generate a blood glucose management action prompt based on the blood glucose management action prompt condition. The diabetes management application can present the blood glucose management action prompt to the patient on a user interface of the mobile device.
Abstract translation: 公开了促使患者进行血糖管理动作的方法和系统。 移动设备上的糖尿病管理应用可以从移动设备接收糖尿病相关信息。 糖尿病管理应用可以基于将所接收的糖尿病相关信息与一个或多个预定的提示标准的比较来鉴定血糖管理动作提示。 糖尿病管理应用可以基于血糖管理动作提示条件产生血糖管理动作提示。 糖尿病管理应用可以在移动设备的用户界面上向患者呈现血糖管理动作提示。
-
公开(公告)号:US20210272671A1
公开(公告)日:2021-09-02
申请号:US17306183
申请日:2021-05-03
Applicant: POPS! Diabetes Care, Inc.
Inventor: Curtis Christensen , Daniel Davis , Erik Davis , Chandler Stormo , Lonny Stormo
IPC: G16H20/30 , A61B5/00 , A61B5/145 , A61B5/151 , A61B5/157 , A61B5/11 , A61B5/1171 , G16H40/63 , G16H10/20 , G16H40/60 , G16H10/60 , G06Q30/02 , G09B5/12 , G09B19/00 , H04L29/06
Abstract: Methods and systems are disclosed for prompting a patient to take a blood glucose management action. A diabetes management application on a mobile device can receive diabetes-related information from the mobile device. The diabetes management application can identify a blood glucose management action prompt based on a comparison of the received diabetes-related information to one or more predetermined prompt criteria. The diabetes management application can generate a blood glucose management action prompt based on the blood glucose management action prompt condition. The diabetes management application can present the blood glucose management action prompt to the patient on a user interface of the mobile device.
-
公开(公告)号:US20180035936A1
公开(公告)日:2018-02-08
申请号:US15786746
申请日:2017-10-18
Applicant: POPS! Diabetes Care, Inc.
Inventor: Curtis Christensen , Daniel Davis , Erik Davis
CPC classification number: A61B5/150572 , A61B5/1411 , A61B5/14532 , A61B5/150022 , A61B5/15019 , A61B5/150213 , A61B5/150267 , A61B5/150358 , A61B5/150412 , A61B5/150503 , A61B5/150633 , A61B5/150664 , A61B5/150862 , A61B5/15087 , A61B5/150893 , A61B5/150969 , A61B5/15101 , A61B5/15105 , A61B5/15142 , A61B5/15144 , A61B5/15151 , A61B5/15163 , A61B5/157 , A61B5/7405 , A61B5/742 , A61B5/7445 , A61B5/7455 , A61B2560/0443 , A61B2562/0295
Abstract: This disclosure provides equipment and processes for blood glucose management. Embodiments may comprise a lancet device that includes a base that supports a lancet and a cover. The cover can move controllably from an un-depressed position to a depressed position when a predetermined force is applied. The cover can provide access to the lancet in the depressed position. In another aspect, a biological test kit may include a reusable module and a disposable module. The disposable module may include one or more lancet devices such as that described above to collect a biological sample, one or more strip stations supporting biological strips and a disposable module connector. The reusable module may support measuring equipment to measure a property of the biological sample and a reusable module connector that engages removably with the disposable module connector.
-
公开(公告)号:US20160324481A1
公开(公告)日:2016-11-10
申请号:US15149121
申请日:2016-05-07
Applicant: POPS! Diabetes Care, Inc.
Inventor: Curtis Christensen , Daniel Davis , Erik Davis , Chandler Stormo , Lonny Stormo
CPC classification number: A61B5/7275 , A61B5/0022 , A61B5/1118 , A61B5/1176 , A61B5/14532 , A61B5/151 , A61B5/157 , A61B5/486 , A61B5/6898 , A61B5/7282 , A61B5/742 , A61B5/746 , A61B5/7475 , A61B2562/0295 , G06F19/321 , G06F19/3475 , G06F19/3481 , G06Q30/0269 , G06Q30/0277 , G09B5/125 , G09B19/0092 , G16H10/20 , G16H40/63 , H04L63/10
Abstract: Methods and systems are disclosed for prompting a patient to take a blood glucose management action. A diabetes management application on a mobile device can receive diabetes-related information from the mobile device. The diabetes management application can identify a blood glucose management action prompt based on a comparison of the received diabetes-related information to one or more predetermined prompt criteria. The diabetes management application can generate a blood glucose management action prompt based on the blood glucose management action prompt condition. The diabetes management application can present the blood glucose management action prompt to the patient on a user interface of the mobile device.
-
-
-
-
-
-
-
-